Eagle Pharmaceuticals, Inc. to Present at 29th Annual Piper Jaffray Healthcare Conference
November 20 2017 - 3:30PM
Business Wire
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or “the
Company”) today announced that Scott Tarriff, Chief Executive
Officer, and Pete Meyers, Chief Financial Officer, will present at
the 29th Annual Piper Jaffray Healthcare Conference as follows:
Date: Wednesday, November 29,
2017 Time: 11:30 a.m. Eastern Standard Time Location: Lotte New
York Palace, New York
Webcast:
https://event.webcasts.com/starthere.jsp?ei=1171368&tp_key=fc44350be5
The presentation will be webcast live at the aforementioned
time, and archived for 30 days thereafter, via the Company’s
website at www.eagleus.com, under the Investors Section.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on
developing and commercializing injectable products that address the
shortcomings, as identified by physicians, pharmacists and other
stakeholders, of existing commercially successful injectable
products. Eagle’s strategy is to utilize the FDA's 505(b)(2)
regulatory pathway. Additional information is available on the
Company’s website at www.eagleus.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171120005649/en/
Investor Relations for Eagle Pharmaceuticals, Inc:Lisa M.
Wilson, 212-452-2793lwilson@insitecony.com
Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
From Apr 2024 to May 2024
Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
From May 2023 to May 2024